Rajeev Gautam

Laboratory of Molecular Microbiology, National Institutes of Health

Affiliated withNational Institutes of Health

Research Area

Biography

Rajeev Gautam has not added Biography.
If you are Rajeev Gautam and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 12	2023

Other Publications

Article	Year
In vitro characterization of primary SIVsmm isolates belonging to different lineages. In vitro growth on rhesus macaque cells is not predictive for in vivo replication in rhesus macaques. Virology\| PubMed ID: 17303205	2007
Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17709518	2007
Cutting edge: Experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18981083	2008
Pattern of SIVagm infection in patas monkeys suggests that host adaptation to simian immunodeficiency virus infection may result in resistance to infection and virus extinction. The Journal of infectious diseases\| PubMed ID: 20887227	2010
Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 22123961	2011
Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies. Journal of virology\| PubMed ID: 22647691	2012
Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strains. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 23129652	2012
Pathogenic features associated with increased virulence upon Simian immunodeficiency virus cross-species transmission from natural hosts. Journal of virology\| PubMed ID: 24696477	2014
Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection. Science translational medicine\| PubMed ID: 26223303	2015
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Nature\| PubMed ID: 27120156	2016
DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 27733554	2016
Early antibody therapy can induce long-lasting immunity to SHIV. Nature\| PubMed ID: 28289286	2017
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS pathogens\| PubMed ID: 29505593	2018
A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection. Nature medicine\| PubMed ID: 29662199	2018
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature\| PubMed ID: 31142836	2019
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia. The Journal of experimental medicine\| PubMed ID: 32966579	2021
A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch. eLife\| PubMed ID: 33084569	2020
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope. NPJ vaccines\| PubMed ID: 34697307	2021
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env. Science translational medicine\| PubMed ID: 34818054	2021
Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer. Nature communications\| PubMed ID: 35136084	2022